Influenza viruses are well recognised for their viral properties such as sialic-acid receptor specificity, glycosylation, virulence, pathogenicity and development of resistance to drug therapy as well as for their high mutation rates, with the ability to generate antigenically distinct variants ([@B13], [@B9], [@B28]). The haemagglutinin (HA) gene presents the highest mutation rates in the influenza genome and its encoded glycoprotein is responsible for the initial steps of successful infection ([@B30]). In April 2009, the World Health Organization (WHO) identified the occurrence of novel human influenza cases in Mexico and the United States of America (USA), which were caused by influenza A(H1N1) of swine origin ([@B8]), thereafter referred to as A(H1N1)pdm09. Within months, the virus had spread worldwide, provoking the first pandemic of the XXI century, accounting for more than 18,000 deaths ([@B35]). In Brazil, the first cases were confirmed by sequencing and real-time reverse transcription-polymerase chain reaction (RT-PCR) on 7 May 2009 in the Southeast Region from travellers arriving from Mexico. Three weeks later, the local transmission of A(H1N1)pdm09 influenza virus was announced by the Brazilian Ministry of Health. In Pernambuco (PE), a northeast state located in an equatorial region (geographic coordinates of Recife municipality, the state's capital: 08º03'14''S 34º52'52''W), the first case was confirmed at the beginning of June 2009.

Since its establishment in the human population, many authors have monitored polymorphisms of the influenza A(H1N1)pdm09 HA gene, which allowed early phylogenetic classification of the virus into seven distinct clades ([@B22]), with clades 6 and 7 being the most prevalent in Brazil and worldwide ([@B20]). Mixed viral populations bearing the D222G/N change have been more frequently reported among severe/fatal cases ([@B14], [@B31], [@B23]). The changes in this residue are associated with an expansion in viral tropism, allowing linkage of the particles to both α2,6 and α2,3 sialic-acid cell receptors, with the latter being found in the majority in the lower respiratory tract of humans ([@B17]). In addition, mutations in the neuraminidase (NA) can lead to a loss of sensitivity to oseltamivir (OST), as observed for seasonal A(H1N1) viruses in different countries before the emergency of the 2009 pandemic virus ([@B5], [@B6], [@B18]). The worldwide dissemination of A(H1N1)pdm09 influenza virus associated with the broad use of OST has demanded increasing surveillance of viral resistance to NA inhibitors. To our knowledge, data published from Brazil's equatorial region are mainly clinical and epidemiological surveys ([@B2], [@B24], Pires Neto et al. 2013, [@B25]), without molecular or phylogenetic data. Taking into account the impact of influenza A(H1N1)pdm09, the unique characteristics of influenza viruses circulating worldwide and the lack of published data on molecular features of the virus from this equatorial region, we seek to investigate the presence of the H275Y change in NA gene and carry out the molecular characterisation of the HA gene from circulating influenza A(H1N1)pdm09 viruses in PE.

SUBJECTS, MATERIALS AND METHODS
===============================

*Clinical samples and molecular diagnosis* - Clinical specimens (combined nose and throat swabs or lung tissue fragments of deceased subjects) were collected from outpatients and hospitalised patients in Recife and its metropolitan area from April 2009-April 2010. These samples were collected in the scope of the Brazilian Influenza Surveillance Network within seven days of onset of influenza-like illness. In hospitalised cases where OST was used, the sample collection was performed before drug administration. After collection, both swabs and tissue fragments were placed in standard virus transport medium at the Pernambuco State Central Laboratory. The samples were then sent frozen to the Evandro Chagas Institute, in PA, for influenza A(H1N1)pdm09 detection by a real-time RT-PCR protocol developed by Centers for Disease Control and Prevention (USA) ([@B33]). The samples confirmed positive for influenza A(H1N1)pdm09 were sent to the Respiratory Viruses Reference Laboratory at Oswaldo Cruz Foundation, Rio de Janeiro, for further molecular characterisation. This study was approved by the Ethics in Research Committee of the Federal University of Pernambuco (protocol CEP/CCS/UFPE 219/10).

*Sequencing of HA genes* - The genetic characterisation of the HA gene from 30 samples from June 2009-April 2010 was performed by the Sanger method. In summary, the HA gene was amplified by RT-PCR using SuperScript III One-step RT-PCR with Platinum *Taq*-DNA Polymerase (Invitrogen, USA) following the protocol released by [@B32]. The amplicons were directly sequenced using Big Dye Terminator Cycle Sequencing Ready Reaction v.3.1 (Applied Biosystems, USA), purified ([@B19]) and run on an ABI 3130XL Capillary Automatic DNA Analyzer, as established by the manufacturer. Sequences of complete HA genes were edited using the Sequencher software, v.5.1 (Gene Codes, USA).

*Phylogenetic analysis* - The data set used for phylogenetic analysis was composed of the 30 HA sequences obtained in this study as well as other Brazilian and worldwide sequences available at GenBank (ncbi.nlm.nih.gov) collected over the period of this study. The complete dataset (5,471 sequences) was split in Brazilian (157, 2.87%) and non-Brazilian small ones. The CD-HIT software (weizhong-lab.ucsd.edu/cd-hit/) was used to select representative sequences of each data set, reducing then to a reasonable size. The identity cut-offs were 99.9% and 99.5% for Brazilian and non-Brazilian groups, respectively. The final data set contained 70 sequences, including two egg-isolated vaccine strains A/California/07/09 (FJ969540) and A/California/04/09 (FJ966082). The complete HA gene sequences were aligned using the CLUSTALW tool integrated within the MEGA 5.2 software ([@B29]). A maximum-likelihood (ML) phylogenetic tree was inferred with the PhyML program (atcg-montpellier.fr/phyml/), using the best-fitting nucleotide substitution model, Hasegawa-Kishino-Yano plus gamma distribution among the sites, which was estimated by means of jModelTest v.2.1.1 software. ML reliability of branches was evaluated using approximate likelihood-ratio test and an interior branch cut-off value was ≥ 0.9. The tree was rooted with two vaccine representative sequences, which fell outside all clades, being used as a basis for comparison.

*Pyrosequencing analysis of NA gene* - A total of 118 influenza A(H1N1)pdm09 positive samples (65 hospitalised and 53 outpatients) were pyrosequenced in order to check for the presence of the resistance marker H275Y in the NA gene, according to a protocol developed previously ([@B4]). After purification, the amplicons were analysed on the Pyromark Q-96 ID (Qiagen, Germany), using the single nucleotide polymorphism (SNP) mode. To carry out the quantitative analysis of H275Y mutation, we investigated the codon change CAC-TAC by pyrosequencing. All samples presenting less than 10% of "T" at the first position of the codon were considered wild type. Conversely, all values above 10% were considered as a mixture of wild and mutant types, with potentially reduced sensitivity to OST treatment.

RESULTS
=======

The details of the 30 samples sequenced in this study, namely strain name, GenBank accession, date and epidemiologic week (EW) of collection and patient type, are summarised in [Table I](#t01){ref-type="table"}. The samples sequenced covered the beginning of the regional circulation of the pandemic virus in PE in June 2009-April 2010. The period with the largest amount of sequences was August-September, between EW 31-38, accounting for 19 sequences. Twenty out of 30 HA sequences came from hospitalised patients, with two fatal cases. Theoretically translated amino acid sequences obtained from these patients held a total of 16 changes in comparison to A/California/07/2009. The changes stratified by patient type and their association to HA epitope regions are listed in [Table II](#t02){ref-type="table"}. The changes P83S and I321V were identified immediately after the introduction of the virus in the human population, being common to all samples outside phylogenetic clade 1 ([@B20]). The second most frequent change was S203T, the signature residue of phylogenetic clade 7 ([@B22]). This change was found in 23 samples (77%) collected from both outpatients or hospitalised subjects and only seven samples were similar to the vaccine prototype for this residue. Out of 30 samples, the Q293H change, characteristic of clade 6, was found in eight sequences in this study; three in outpatient subjects and five in samples from hospitalised patients. This change was combined with a K-15E mutation (in the HA signal peptide) in seven out of eight samples, the unique exception being A/Pernambuco/175/2009 (CY103914) from the outpatient group. Residue changes S84N, D97N and P182Q were found both in outpatient and hospitalised groups and the mutation K308E was identified in one sample from 2009 (CY103928) and three from 2010 (CY103938, CY103939 and CY103940), all from hospitalised patients. A further six changes were identified once or twice in this study, also in hospitalised or deceased patients, namely: G39E, S71F, D222N/G, N260K, Y351F and D472G. The sequences in this study were also analysed for the presence of putative HA virulence markers D222G ([@B34]) and Q293H ([@B10]). A mixed viral population D222N/G, presenting as a double peak on the Sanger electropherogram ([Supplementary data](#app01){ref-type="app"}), was identified in sample A/Pernambuco/643/2009 (CY103935) from a deceased patient. On the other hand, the change Q239H was detected in eight samples, all from 2009, including a sample from a deceased pregnant woman bearing the mixture N/G at residue 222. The ML phylogenetic analysis of complete HA sequences from PE was carried out along with global representative sequences available in GenBank ([Figure](#f01){ref-type="fig"}). PE sequences were divided in two major groups on the ML tree, represented by red branches and the most frequent amino acid changes are represented at the branches. Seven samples were allocated to clade 6 and 23 to clade 7. No chronological or geographic segregation was detected between PE and south-southeastern Brazilian samples, being clustered altogether in both clades. The pyrosequencing assay was performed in order to detect for the anti-viral resistance genetic marker H275Y of the NA gene. A total of 118 samples from hospitalised and outpatients patients positive for influenza A(H1N1)pdm09 by RT-PCR were assayed using pyrosequencing methodology and none presented a tyrosine at residue 275.

TABLE IInfluenza A(H1N1)pdm09 positive samples sequenced in this studyStrain identificationGenBank accessionEW collectionCollection datePatient typeA/Pernambuco/42/2009CY1039232527 June 2009OA/Pernambuco/66/2009CY1039362629 June 2009HA/Pernambuco/82/2009CY103941262 July 2009OA/Pernambuco/107/2009CY1039112817 July 2009OA/Pernambuco/117/2009CY1039122923 July 2009OA/Pernambuco/126/2009CY1039132925 July 2009OA/Pernambuco/175/2009CY103914315 August 2009OA/Pernambuco/177/2009CY103915315 August 2009OA/Pernambuco/181/2009CY103916315 August 2009OA/Pernambuco/231/2009CY103917319 August 2009HA/Pernambuco/247/2009CY1039183211 August 2009HA/Pernambuco/402/2009CY1039203319 August 2009HA/Pernambuco/397/2009CY1039193424 September 2009HA/Pernambuco/414/2009CY1039223425 August 2009HA/Pernambuco/431/2009CY1039243427 August 2009OA/Pernambuco/447/2009CY1039253430 August 2009HA/Pernambuco/458/2009CY1039263428 August 2009HA/Pernambuco/513/2009CY103927353 September 2009HA/Pernambuco/518/2009CY103928354 September 2009HA/Pernambuco/565/2009CY1039293611 September 2009HA/Pernambuco/567/2009CY1039303612 September 2009HA/Pernambuco/590/2009CY1039313718 September 2009HA/Pernambuco/592/2009CY1039323718 September 2009HA/Pernambuco/609/2009CY1039333722 September 2009HA/Pernambuco/624/2009CY1039343824 September 2009HA/Pernambuco/643/2009CY103935393 October 2009DA/Pernambuco/688/2009CY103937444 November 2009OA/Pernambuco/732/2010CY103938214 January 2010HA/Pernambuco/744/2010CY10393996 March 2010HA/Pernambuco/768/2010CY1039401515 April 2010D[^1]

TABLE IIMutations in complete neuraminidase gene segments associated with patient characteristics and antigenic sitesAmino acid changes^*a*^HA epitopePatient type (n)Total (n)Outpatient (n = 10)Hospitalised (n = 18)Deceased (n = 2)K-15E-2417G39E\--1-1S71FCb-1-1S74NCb12-3P83S-1018230S84N-11-2D97N-32-5P182Q-14-5S203TCa~1~814123D222N/G^*b*^Ca~2~\--11N260K\--1-1Q293H-3418K308E\--314I321V-1018230Y351F^*c*^\-\--11D472G^*c*^\--117[^2]

Maximum-likelihood (ML) phylogenetic tree of complete neuraminidase gene representing influenza A(H1N1)pdm09 viruses circulating in the state of Pernambuco (PE) from June 2009-April 2010. PE sequence names are in red to differentiate from other representative sequences from the equivalent period available in the GenBank database. ML reliability of branches was evaluated using an approximate likelihood-ratio test and the interior branch cut-off value was ≥ 0.9 indicated by an asterisk. All samples sequenced in this study are classified in clades 6 and 7 that co-circulate. Major associated amino acid changes are indicated in the branches using H1 numbering without signal peptide. The tree is rooted with egg-isolated vaccine strain A/California/07/09 (FJ969540). †: deceased patients.

DISCUSSION
==========

It is noteworthy that whereas HA mutations S84N, D97N and P182Q were found in both outpatient and hospitalised groups, the change K308E was found only in severe cases. The K308E change was detected in one sample collected on 4 September 2009 from a hospitalised patient (CY103928) and thereafter in three other samples from the beginning of 2010, collected from two hospitalised (CY103938, CY103939) and a deceased patient (CY103940) (Table II). Based on sequences available in GenBank for this period, the K308E change first appeared in the Brazilian equatorial area and only in the next year in other tropical and temperate countries such as Singapore, England, Spain and USA. It is also worth noting that for Brazilian samples this change was not associated with V47I or E172K as observed in samples from the genetic group represented by A/Madrid/SO8171/10 identified in Spain ([@B15]). It remains to be seen if such changes are responsible for the severity of the cases and conversely if these changes were provoked by a longer period of viral replication in the lower respiratory tract. Scattered residue changes have been identified in severely immunosuppressed cancer patients and were associated to long shedding periods ([@B27]). In our study the patients were sampled once therefore it was not possible follow the evolution of the virus during the course of illness. Nevertheless, a greater diversity in the HA gene was distinguished in the hospitalised group when compared with the outpatient group, as observed by the amount of single mutations in hospitalised subject sequences.

In addition, we studied the possible association between the patient's clinical status and the presence of HA virulence markers D222G and Q293H. A mixed viral population D222N/G (a double peak on the Sanger electropherogram) was identified in one sample only from this study. The amino acid residue 222 is located in the receptor binding site of HA and alterations in this site can affect the cellular tropism of the virus, rendering particles more prone to infecting the lower respiratory tract, thus, provoking severe disease. This hypothesis is in agreement with a fatal outcome from a pregnant woman that developed pneumonia with pulmonary condensation on chest radiography. The other putative virulence marker Q293H was detected in a similar proportion both in outpatient samples as well in hospitalised samples; therefore, we could not associate this mutation with more severe or fatal cases. Such findings corroborate the results previously reported from Brazilian and Indian samples ([@B16], [@B22]). Phylogenetic relationships between PE HA sequences, south-southeastern Brazilian and other worldwide isolates can be seen in Figure. PE sequences were classified in co-circulating clades 6 and 7, as observed in distinct regions of the world ([@B20]). The majority of PE sequences are in clade 7, grouped together with other sequences from the same period from the states of Santa Catarina and Rio Grande do Sul, in southern Brazil, geographically distant from PE. Both clusters enclosed minor sub-clusters, most of them characterised by single amino acid changes, however, all samples were similar to the vaccine prototype, as observed by other authors ([@B1], [@B12]). All samples in clade 6 presented the signature mutation Q293H, whereas this mutation was found only in two samples in clade 7: A/Pernambuco/175/09 (CY103914) and A/Pernambuco/414/09 (CY103922).

The H275Y marker was not detected in the 118 samples evaluated in this study. This finding is in agreement with previous data, that suggest a very low frequency of resistance in influenza A(H1N1)pdm09 in comparison to seasonal viruses ([@B27], [@B36]) during the period the samples were collected. However, the expected levels of resistance detected in south-southeastern states in Brazil ([@B26]) and in Argentina ([@B3]) since 2011, as well as the increasing number of resistant strains reported worldwide ([@B11], [@B26]) indicate the need for broader monitoring of resistance in equatorial areas of Brazil.

In this study, some important features of influenza A(H1N1)pdm09 HA and NA genes were described from samples collected in PE during the 2009-2010 biennium. There was no significant difference in PE HA sequences when compared with those from other Brazilian regions as samples from distinct regions were extensively grouped together in the phylogenetic tree. These regional sub-clusters, formed by samples collected between July/2009-April/2010, are indicative of co-circulation of lineages, as previously observed ([@B7]). In addition, the NA resistance marker H275Y was not identified by pyrosequencing in any of the 118 samples tested, confirming the stability of the NA of the pandemic virus during the pandemic year. However, continuous monitoring of viral evolution and the emergence of OST resistance are pivotal for worldwide influenza surveillance and the findings depicted here contribute to a better understanding of the genetic characteristics of the influenza A(H1N1)pdm09 virus that circulated during the pandemic period in the Northeast Brazil.
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[^1]: D: deceased; EW: epidemiologic week; H: hospitalised; O: outpatient.

[^2]: *a*: numbering according to H1 subtype without the signal peptide; *b*: N/G: a double peak (A/G) at the first base of the 222 codon; *c*: HA2 region; HA: haemagglutinin.
